Skip to main content
Equibles
NAMSW logo

NAMSW · NewAmsterdam Pharma Co N.V. · Exempt Offerings

Track NAMSW — free

Use NAMSW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NAMSW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.25 -1.00 (-10.81%) At close · Oct 26 Q3 2025 earnings call transcript
Rebalance outlook locked
Market Cap
$2.45B
Shares
119.54M
Volume · Oct 26 241 Avg daily vol (3M) 2621

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

No Exempt Offerings

No Form D exempt-offering notices are available for this stock yet.

Key facts CIK 1936258 CUSIP N62509109 Visit website Investor relations